Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Berlin - Delayed Quote EUR

Merck KGaA (MRK.BE)

Compare
135.95
+1.55
+(1.15%)
At close: February 21 at 8:00:56 AM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
20,963,000
20,993,000
22,232,000
19,687,000
17,534,000
Cost of Revenue
8,679,000
8,600,000
8,527,000
7,351,000
6,835,000
Gross Profit
12,284,000
12,393,000
13,705,000
12,336,000
10,699,000
Operating Expense
8,913,000
8,816,000
8,953,000
8,127,000
7,889,000
Operating Income
3,371,000
3,577,000
4,752,000
4,209,000
2,810,000
Net Non Operating Interest Income Expense
-100,000
-151,000
-157,000
-229,000
-353,000
Pretax Income
3,368,000
3,484,000
4,287,000
3,924,000
2,630,000
Tax Provision
664,000
650,000
948,000
859,000
637,000
Net Income Common Stockholders
2,696,000
2,824,000
3,326,000
3,055,000
1,987,000
Diluted NI Available to Com Stockholders
2,696,000
2,824,000
3,326,000
3,055,000
1,987,000
Basic EPS
6.19
6.49
7.65
7.03
4.57
Diluted EPS
6.19
6.49
7.65
7.03
4.57
Basic Average Shares
435,144.21
434,777.88
434,777.88
434,777.88
434,777.88
Diluted Average Shares
435,144.21
434,777.88
434,777.88
434,777.88
434,777.88
Total Operating Income as Reported
3,442,000
3,609,000
4,474,000
4,179,000
2,985,000
Total Expenses
17,592,000
17,416,000
17,480,000
15,478,000
14,724,000
Net Income from Continuing & Discontinued Operation
2,696,000
2,824,000
3,326,000
3,055,000
1,987,000
Normalized Income
2,654,251.78
2,813,431
3,512,993
3,069,839
1,811,949.43
Interest Income
200,000
172,000
71,000
46,000
39,000
Interest Expense
298,000
321,000
235,000
272,000
387,000
Net Interest Income
-100,000
-151,000
-157,000
-229,000
-353,000
EBIT
3,666,000
3,805,000
4,522,000
4,196,000
3,017,000
EBITDA
5,756,000
5,685,000
6,552,000
5,963,000
4,955,000
Reconciled Cost of Revenue
8,679,000
8,600,000
8,527,000
7,351,000
6,835,000
Reconciled Depreciation
2,090,000
1,880,000
2,030,000
1,767,000
1,938,000
Net Income from Continuing Operation Net Minority Interest
2,696,000
2,824,000
3,326,000
3,055,000
1,987,000
Total Unusual Items Excluding Goodwill
52,000
13,000
-237,000
-19,000
231,000
Total Unusual Items
52,000
13,000
-237,000
-19,000
231,000
Normalized EBITDA
5,704,000
5,672,000
6,789,000
5,982,000
4,724,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
10,251.78
2,431
-50,007
-4,161
55,949.43
12/31/2020 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EVT.VI Evotec SE
8.50
-0.82%
 
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
-33.33%
 
BOI.PA Boiron SA
25.20
+1.00%
 
N4P.L N4 Pharma Plc
0.5750
0.00%
 
TEV.F Teva Pharmaceutical Industries Limited
16.10
-2.13%
 
MERK.JK PT Merck Tbk
3,460.00
+0.29%
 
MOB.ST Moberg Pharma AB (publ)
9.06
-0.06%
 
CINPHA.ST Cinclus Pharma Holding AB (publ)
16.00
+1.89%
 
SECARE.ST Swedencare AB (publ)
46.08
+0.88%
 
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%